TOP TIERMARKET NEWSWIRE
News & sentiment

QUINCE THERAPEUTICS (QNCX) — News & AI sentiment

QUINCE THERAPEUTICS (QNCX) news roundup. 11 stories aggregated over the last 30 days. Average 30-day sentiment is 50.7/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
11
avg sentiment 50.7/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

QNCX news in the last 24 hours, 7 days, 30 days and 90 days

How much QNCX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowQNCX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days1150.7/100QNCX headlines →
Last 90 days2051.9/100QNCX headlines →

Latest stories on QNCX

Sep 4
Sep 3
Sep 3
Aug 27
Aug 20
Aug 20
Quince Therapeutics stock rating reiterated by Cantor Fitzgerald
Investing.com Analyst Ratings50 · neutralanalyst
Aug 18
Aug 17
Aug 17
Aug 17
Aug 14
Aug 14
Aug 14
Aug 14
Jul 31
Jul 30
Quince Surpasses $2 Billion in Sales
Yahoo Finance73 · bullishgeneral
Jul 29
Jun 30
Jun 26
Jun 26
Jun 11
Jun 11
Jun 11
May 21
May 21
Open QNCX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →